Evidence mapPaperPMID 40710784Full record

ArticleJournal of cardiovascular development and disease2025

Stroke Risk Stratification in Incident Atrial Fibrillation: A Sex-Specific Evaluation of CHA2DS2-VA and CHA2DS2-VASc.

Jose L Clua-Espuny, Anna Panisello-Tafalla, Jorgina Lucas-Noll, Eulàlia Muria-Subirats, Teresa Forcadell-Arenas, Juan M Carrera-Ortiz, Pedro Molto-Balado, Josep Clua-Queralt, Immaculada Fusté-Anguera, Silvia Reverte-Vilarroya and 1 more

Abstract read
In one paragraph

Article in Journal of cardiovascular development and disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Observational
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jose L Clua-EspunyInstitut Català de la Salut, SAP Terres de l'Ebre, 43500 Tortosa, Spain.ORCID 0000-0002-6508-5741
Anna Panisello-TafallaPrimary Health-Care Centre Tortosa Est, Institut Català de la Salut, Primary Care Service (SAP) Terres de l'Ebre, 43500 Tortosa, Spain.
Jorgina Lucas-NollDirecció Assistencial, Hospital Comarcal Mora d'Ebre, Salut Terres de l'Ebre, 43740 Tarragona, Spain.
Eulàlia Muria-SubiratsPrimary Health-Care Centre Amposta, Institut Català de la Salut, Primary Care Service (SAP) Terres de l'Ebre, 43870 Amposta, Spain.ORCID 0000-0002-0119-9387
Teresa Forcadell-ArenasPrimary Health-Care Centre Tortosa Oest, Institut Català de la Salut, Primary Care Service (SAP) Terres de l'Ebre, 43500 Tortosa, Spain.
Juan M Carrera-OrtizPrimary Health-Care Centre Tortosa Est, Institut Català de la Salut, Primary Care Service (SAP) Terres de l'Ebre, 43500 Tortosa, Spain.
Pedro Molto-BaladoCSI Llíria, Departament de Salut de Arnau de Vilanova, Conselleria de Sanitat, Llíria, 46010 Valencia, Spain.ORCID 0000-0002-2703-0408
Josep Clua-QueraltPrimary Health-Care Centre Tortosa Est, Institut Català de la Salut, Primary Care Service (SAP) Terres de l'Ebre, 43500 Tortosa, Spain.
Immaculada Fusté-AngueraPrimary Health-Care Centre Tortosa Est, Institut Català de la Salut, Primary Care Service (SAP) Terres de l'Ebre, 43500 Tortosa, Spain.
Silvia Reverte-VilarroyaNursing Department, Advanced Nursing Research Group at Rovira i Virgili University, Biomedicine Doctoral Programme Campus Terres de l'Ebre, Av. De Remolins, 13, 43500 Tortosa, Spain.ORCID 0000-0002-2052-9978
GECATE Project

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

(1) Background: In the absence of locally validated tools, the CHA2DS2-VA score has been suggested as a substitute for the CHA2DS2-VASc score. This study compared the potential discrepancies between these scores. (2) Methods: The observational, retrospective, and community-based study included a cohort of 3370 patients with a new diagnosis of atrial fibrillation (AF) between 1 January 2015 and 31 December 2024. (3) Results: AF prevalence was 8.4%, which was significantly higher in men. The mean age was 80.1 (SD ± 6.24) years. Women (42.8%) were older (80.9 SD ± 6.1 vs. 79.5 SD ± 6.23;

Indexed as

anticoagulationatrial fibrillationCHA2DS2-VASc scoreepidemiological studiessexstroke-risk

Identifiers

PMID40710784
PMCPMC12294841

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.